|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.49 USD | -4.88% |
|
-5.71% | -5.43% |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 2.07B | 2.25B | 2.02B | 1.95B | 1.93B | |||||
Total Revenues | 2.07B | 2.25B | 2.02B | 1.95B | 1.93B | |||||
Cost of Goods Sold, Total | 1.38B | 1.47B | 1.22B | 1.09B | 950M | |||||
Gross Profit | 688M | 782M | 795M | 863M | 983M | |||||
Selling General & Admin Expenses, Total | 438M | 465M | 571M | 524M | 546M | |||||
R&D Expenses | 110M | 132M | 188M | 239M | 272M | |||||
Other Operating Expenses, Total | 548M | 597M | 758M | 763M | 817M | |||||
Operating Income | 140M | 185M | 36.86M | 100M | 166M | |||||
Interest Expense, Total | -2.38M | -1.99M | -1.52M | -2.5M | -1.82M | |||||
Interest And Investment Income | 1.12M | 634K | 4.19M | 4.68M | 10.07M | |||||
Net Interest Expenses | -1.26M | -1.35M | 2.67M | 2.18M | 8.24M | |||||
Currency Exchange Gains (Loss) | -150K | -1.78M | 19.66M | -7.55M | -3.53M | |||||
Other Non Operating Income (Expenses) | -525K | 5.07M | 154K | 2.89M | -1.62M | |||||
EBT, Excl. Unusual Items | 138M | 187M | 59.34M | 97.73M | 169M | |||||
Restructuring Charges | -19.99M | -21.7M | - | -23M | -8.5M | |||||
Merger & Related Restructuring Charges | -286K | -11.26M | -12.58M | - | - | |||||
Asset Writedown | -10.9M | - | - | - | -5.69M | |||||
Legal Settlements | - | - | - | - | - | |||||
Other Unusual Items | - | - | -4.7M | - | - | |||||
EBT, Incl. Unusual Items | 107M | 154M | 42.06M | 74.73M | 154M | |||||
Income Tax Expense | 32.2M | 16.17M | 31.19M | 20.08M | 39.78M | |||||
Earnings From Continuing Operations | 74.69M | 138M | 10.88M | 54.64M | 115M | |||||
Net Income to Company | 74.69M | 138M | 10.88M | 54.64M | 115M | |||||
Minority Interest | -3.01M | -3.19M | -1.92M | -1.38M | -3.14M | |||||
Net Income - (IS) | 71.68M | 134M | 8.95M | 53.26M | 112M | |||||
Net Income to Common Incl Extra Items | 71.68M | 134M | 8.95M | 53.26M | 112M | |||||
Net Income to Common Excl. Extra Items | 71.68M | 134M | 8.95M | 53.26M | 112M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 1.18 | 2.21 | 0.15 | 0.95 | 2.04 | |||||
Basic EPS - Continuing Operations | 1.18 | 2.21 | 0.15 | 0.95 | 2.04 | |||||
Basic Weighted Average Shares Outstanding | 60.88M | 60.72M | 60M | 56.17M | 54.82M | |||||
Net EPS - Diluted | 1.16 | 2.09 | 0.14 | 0.88 | 1.9 | |||||
Diluted EPS - Continuing Operations | 1.16 | 2.09 | 0.14 | 0.88 | 1.9 | |||||
Diluted Weighted Average Shares Outstanding | 61.82M | 64.23M | 62.76M | 60.23M | 58.61M | |||||
Normalized Basic EPS | 1.37 | 1.87 | 0.59 | 1.06 | 1.87 | |||||
Normalized Diluted EPS | 1.35 | 1.77 | 0.56 | 0.99 | 1.75 | |||||
American Depositary Receipts Ratio (ADR) | 1 | 1 | 1 | 1 | 1 | |||||
Supplemental Items | ||||||||||
EBITDA | 203M | 251M | 126M | 173M | 267M | |||||
EBITA | 140M | 185M | 70.26M | 121M | 226M | |||||
EBIT | 140M | 185M | 36.86M | 100M | 166M | |||||
EBITDAR | 259M | 300M | 159M | 210M | 307M | |||||
Effective Tax Rate - (Ratio) | 30.12 | 10.51 | 74.14 | 26.88 | 25.75 | |||||
Current Domestic Taxes | 16.38M | 16.55M | 5.66M | 3.76M | 9.94M | |||||
Current Foreign Taxes | 12.1M | 18.26M | 21.92M | 39.92M | 55.88M | |||||
Total Current Taxes | 28.48M | 34.81M | 27.58M | 43.67M | 65.82M | |||||
Deferred Domestic Taxes | -4.55M | -9.57M | 5.87M | 634K | -1.3M | |||||
Deferred Foreign Taxes | 8.27M | -9.07M | -2.27M | -24.22M | -24.74M | |||||
Total Deferred Taxes | 3.72M | -18.64M | 3.6M | -23.59M | -26.04M | |||||
Normalized Net Income | 83.28M | 114M | 35.17M | 59.7M | 102M | |||||
Interest on Long-Term Debt | 2.91M | 2.27M | 2.02M | 2.4M | - | |||||
Non-Cash Pension Expense | 95K | 51K | 73K | 161K | 158K | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | - | - | - | 1.7M | 1.9M | |||||
Marketing Expenses | 6.66M | 14.02M | - | - | - | |||||
Selling and Marketing Expenses | 6.66M | 14.02M | - | 1.7M | 1.9M | |||||
General and Administrative Expenses | 96.88M | 121M | 193M | 132M | 171M | |||||
Research And Development Expense From Footnotes | 149M | 169M | 202M | 242M | 279M | |||||
Net Rental Expense, Total | 55.88M | 49.07M | 33.54M | 37.27M | 40.61M | |||||
Imputed Operating Lease Interest Expense | 7.03M | 5.92M | 3.43M | 6.47M | 5.18M | |||||
Imputed Operating Lease Depreciation | 48.85M | 43.15M | 30.11M | 30.8M | 35.43M | |||||
Stock-Based Comp., R&D Exp. (Total) | 10.25M | 16.33M | 36.51M | 54.79M | 54.03M | |||||
Stock-Based Comp., G&A Exp. (Total) | 9.13M | 15.6M | 14.32M | 22.38M | 27.13M | |||||
Stock-Based Comp., SG&A Exp. (Total) | 12.04M | 13.02M | 14.2M | 20.01M | 21.46M | |||||
Stock-Based Comp., Other (Total) | -2.66M | -427K | 1K | - | - | |||||
Total Stock-Based Compensation | 28.77M | 44.53M | 65.04M | 97.18M | 103M |
- Stock Market
- Equities
- CRTO Stock
- Financials Criteo S.A.
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















